Fortis Healthcare (India) today said it has completed acquisition of 74.59% stake in Super Religare Laboratories (SRL).

The company's board had earlier accorded approval to acquire 86% stake in SRL from promoters.

Also Read   Related Stories News Now - Sabre Partners to invest Rs 50 cr in SRL in pre-IPO deal - Fortis to list 2 entities worth $1.5 bn in Singapore - Avigo Capital buys 9.27% stake in SRL for Rs 100 cr - Avigo Capital Partners picks up 9% stake in SRL - Fortis to buy 86% in Super Religare Labs - Fortis to buy 86% in Super Religare Laboratories

Also Read   Related Stories News Now - Markets end flat - Turbulence ahead for airlines despite oil price drop - Weak rupee may bring cheer to NRIs, expats - LIC buys PSU stocks, sells pvt sector blue-chips in Q4 - Banks may lower deposit rates as inflation eases: Report More

Based on the valuation of 9.27% stake sale to private equity firm Avigo Capital Partners by SRL, Fortis is expected to pay around Rs 930 crore for 86% stake in the company.

Avigo Capital Partners had picked up 9.27% stake in SRL in a pre-IPO placement for an aggregate amount of nearly Rs 100 crore.

Both Fortis Healthcare and SRL are promoted by billionaire brothers Malvinder Mohan Singh and Shivinder Mohan Singh.

In February this year, SRL had filed a Draft Red Herring Prospectus (DRHP) with the Securities Exchange Board of India (Sebi) for a public issue of 28 million shares and the document is awaiting comments from Sebi, it said.

As per the DRHP, promoter and promoter groups held 85.67% sake in SRL.

Super Religare Laboratories, which is one of the largest diagnostics provider in the country, acquired Piramal Diagnostic Services (PDSPL) in August 2010 for Rs 600 crore to strengthen its presence in the radiology services.

SRL's present network consists of 8 reference laboratories, 7 centres of excellence, 181 network laboratories (164 pathology, 17 radiology), 15 wellness centres and 888 collection centres.

Fortis had recently launched C-Doc for diabetes and metabolic diseases and stem cell therapy centres.

Fortis commissioned its first hospital in 2001 at Mohali, and has grown into a network of 56 hospitals with an over 8,000 bed capacity.

Shares of Fortis Healthcare today closed at Rs 156 on the BSE, down 0.64% from its previous close.

New Ipad Application :Business Standard's all new IPad App Click here to download for free Other Stories      - Markets end flat - Turbulence ahead for airlines despite oil price drop - Weak rupee may bring cheer to NRIs, expats - LIC buys PSU stocks, sells pvt sector blue-chips in Q4 - Banks may lower deposit rates as inflation eases: Report

Tags : Fortis Healthcare | Super Religare Laboratories | SRL | stake buy   Read Business news in  Advertisements -  Journey on, We are by Your Side. Click here to know more -  2 Lac Apartments, 1 Lac House / Plots. Click here -  Benefits Upto Rs. 2.36 Lakhs on the Fully Loaded TJet Petrol. -  The Best Seller is Also the No. 1 in Mileage. Click here -  Watch The Film Here. Click here to know more.. -  Leader in Passenger Car & Automobile Tyres. Click here -  1 billion in saving for Unilever without any tangles. -  A Brand New Server at a Price That Fits Your Budget. Click here -  Learn How One City is Running on FOOD SCRAPS. -  One Partnership Endless Possibilities. Click here to know more -  Helping doctors detect diseases earlier, saving costs & extending lives. -  36 Lakhs can get you a pool of Luxuries. Click here -  Which is the best plan for your daughter -  Check out the TRUE COLOURS of your Stocks, Now for FREE! -  One of the leading business schools in the world.Know More